Clinical Trials Directory

Trials / Completed

CompletedNCT03777787

Bitter Tastants and Reflux

The Relationship Between Acute Administration of a Bitter Compound and Transient Lower Esophageal Sphincter Relaxations and Reflux Events in Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Recently the relationship between intragastric pressure (IGP) and reflux events after a meal was investigated, both in gastro-esophageal reflux disease (GERD) patients and in healthy volunteers. Ingestion of a meal was accompanied by a drop in IGP. However, the magnitude of this drop varied and was inversely correlated with the number of transient lower esophageal sphincter relaxations (TLESRs) and the number of reflux events, both in patients and in healthy volunteers: a smaller meal-induced drop in IGP was associated with a higher rate of reflux events and vice versa. This finding suggests that a smaller meal-induced drop may act as a trigger for reflux. It has been demonstrated that bitter administration leads to a smaller meal-induced drop. Therefore, bitter can be a dietary trigger for TLESRs facilitating the occurrence of symptoms of GERD. To evaluate this hypothesis, the researchers will study the relationship between bitter and the occurrence of TLESRs and reflux events in healthy volunteers. Additionally, it has been demonstrated that administering bitter also influences the concentration of motilin. Therefore, the research team will also measure the concentration of motilin to investigate whether changes in motilin concentrations can influence the number of TLESRs, via a change in gastric tone.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDenatonium BenzoateA single intragastric administration of denatonium benzoate (1 µmol/kg)
DIETARY_SUPPLEMENTWaterA single intragastric administration of water

Timeline

Start date
2019-01-14
Primary completion
2019-05-10
Completion
2019-05-10
First posted
2018-12-17
Last updated
2019-06-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03777787. Inclusion in this directory is not an endorsement.